Welcome to HCV Advocate’s hepatitis blog. The intent of this blog is to keep our website audience up-to-date on information about hepatitis and to answer some of our web site and training audience questions. People are encouraged to submit questions and post comments.
For more information on how to use this blog click here, the HCV drug pipeline click here, and for more information on HCV clinical trials click here
Thursday, January 27, 2011
Peginterferon Promising for Hepatitis Delta Virus
WEDNESDAY, Jan. 26 (HealthDay News) -- Peginterferon alfa-2a, with or without adefovir, shows promise in the treatment of hepatitis delta virus (HDV), according to research published in the Jan. 27 issue of the New England Journal of Medicine.
The researchers found that two patients in the peginterferon plus adefovir group, two patients in the peginterferon plus placebo group, and none of the patients in the adefovir group achieved normalization of alanine aminotransferase levels and clearance of HDV RNA by week 48.